Phreesia, Inc. (NYSE:PHR) COO Sells $172,507.05 in Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 7,233 shares of Phreesia stock in a transaction that occurred on Tuesday, April 8th. The shares were sold at an average price of $23.85, for a total value of $172,507.05. Following the completion of the transaction, the chief operating officer now owns 776,652 shares of the company’s stock, valued at approximately $18,523,150.20. The trade was a 0.92 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Evan Roberts also recently made the following trade(s):

• On Tuesday, February 18th, Evan Roberts sold 3,519 shares of Phreesia stock. The shares were sold at an average price of $30.06, for a total transaction of $105,781.14.
• On Thursday, February 13th, Evan Roberts sold 16,005 shares of Phreesia stock. The stock was sold at an average price of $30.00, for a total value of $480,150.00.
• On Monday, January 27th, Evan Roberts sold 10,716 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total transaction of $294,475.68.
• On Tuesday, January 21st, Evan Roberts sold 12,749 shares of Phreesia stock. The shares were sold at an average price of $27.31, for a total value of $348,175.19.
• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total transaction of $48,159.30.

Phreesia Trading Up 0.3 %

Phreesia stock opened at $24.06 on Friday. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $30.53. The stock has a market cap of $1.41 billion, a price-to-earnings ratio of -16.37 and a beta of 0.82. The business has a 50 day moving average price of $26.57 and a two-hundred day moving average price of $24.26. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Piper Sandler restated an “overweight” rating and issued a $33.00 target price (up from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. Canaccord Genuity Group upped their price objective on shares of Phreesia from $34.00 to $35.00 and gave the company a “buy” rating in a research note on Thursday, March 13th. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and raised their price target for the stock from $24.00 to $32.00 in a research note on Wednesday, January 8th. Citigroup lifted their price objective on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, January 10th. Finally, KeyCorp upped their target price on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 8th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Phreesia currently has an average rating of “Buy” and a consensus target price of $31.33.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of PHR. Johnson Financial Group Inc. boosted its holdings in Phreesia by 381.3% during the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock valued at $28,000 after purchasing an additional 896 shares in the last quarter. R Squared Ltd bought a new stake in shares of Phreesia during the fourth quarter worth $30,000. BankPlus Trust Department bought a new stake in Phreesia during the 4th quarter worth about $34,000. Quarry LP grew its stake in shares of Phreesia by 210.9% during the fourth quarter. Quarry LP now owns 2,835 shares of the company’s stock valued at $71,000 after purchasing an additional 1,923 shares during the last quarter. Finally, Venturi Wealth Management LLC acquired a new stake in shares of Phreesia in the 4th quarter valued at $76,000. 92.10% of the stock is owned by institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.